'Bennett said the goal is to build a preclinical data package that shows efficacy across orthopoxviruses, which include mpox and smallpox, and then generate "robust" phase 1/2 data to inform dose selection and eventually licensure.'

#monkeypox #smallpox #vaccine

https://www.fiercebiotech.com/biotech/bio-moderna-test-mpox-vaccine-humans-summer